edovogopu.wordpress.com
The money was grante d in collaboration withthe U.S. Army Medical Research and Materiel Command and the througgthe Ft. Detrick Technology Transfer Initiative. The purposd of the technology transfer program is to raiser awareness of new and developing technologies and fundinb them to transition as viable projectsfor follow-on fundingg in the market place. Each company that receivexd funding was awardedapproximately $50,009 between March 2008 and May 2009, makiny up the initiative’s second round of financial awards sincee its $750,000 program extension. The fundd for the program’s seconxd phase were secured by Sen. Barbara Mikulski, and Rep. Roscoe G. Bartlett, “The [Ft.
Detrick Technology Transfet Initiative] program is enablintg area businesses to harness the technologiesd being developed at Fort Detrick and applgy them to thecommercial sector,” said “This will lead to new productss that have the power to creatr jobs and save lives.” Mikulskii announced the first phase of the tech transfer programm in March 2005 when 11 companies received in Rockville: The company is developing a healthb care technology called miTag system, whicj is a scalable wireless sensor solution for improving patiengt flow. in Frederick: The companhy is developing a technology callef the GeNova Screento identify, isolate, and producd antibody-like molecules.
in Rockville: The company is developing an on-demanf biotech products including a combinationn vaccine against plagueand anthrax. BioAssay Works LLC in The company is developinga lateral-flowq visual diagnostic test to detect and differentiat e single sample multiple pathogenixc poxviruses, including variola, vaccinia, and in Catonsville: The company is safety-testinv a medical product calles ClotFoam, which is a intracavitary hemostatic agent.
CynerGene IDMP in Frederick: The companyh is developing, validating and implementing a supplemental diagnosis of Malaria, HIV, and Dengue usinb its Infectious Disease Multiplexs Panel approach, which coul d allow for creation of LLC in Baltimore: The company is developing requirex components and system framework to enable conversational interfacesw for telemedicine tools. Such tools would allow professiona l medics touse voice, and other human-- computer interactionw to access and document information in electronic medicao records. in Rockville: The company is developing technology to preserve mammaliajn cells in dried format that can easilybe re-hydrated for a variethy of uses.
LLC in Frederick: The companhy is evaluating the effect of Imagilinj patented probiotics as a food supplement to enhance the immund responsiveness of guinea pigs upon immunization or challengre withvirulent pathogens. The evaluatio n will suggest the ability of Imagilin patentedd probiotics to enhance the immunization of a in Baltimore: The company is developing micropatterned substrates for virall infectivity assays. Juxtopia in Baltimore: The company is customizinh its Wearable Assistance and Situational Awareness goggles and service toallow U.S. Army comba t medics to access and document information to electrical medicalo recordsvia hands-free voice-requestes and voice-responses.
in Baltimore: The company is developing cell therapies to treat brain and spinalcord
No comments:
Post a Comment